{
    "nctId": "NCT03870802",
    "briefTitle": "MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)",
    "officialTitle": "Evaluation of Stem and Immune Cells in the Early Stage Breast Cancer Without Genetic Risk",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "To characterise quantitatively and qualitatively, after solitary confinement, the resident breast stem cells and the immune system cells infiltrated in the mammary gland according to the risk of breast cancer progression (group A and B)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 years\n* Patient requiring a breast surgery (total mastectomy) of an early stage tumour classified as :\n\n  * Luminal A (Arm A) : Patients with a moderate risk of breast cancer progression or,\n  * Luminal B or Basal (Arm B) : Patients with a high risk of breast cancer progression\n* Systemic treatment not initiated\n* Breast cup size \u2265 C\n* Informed and signed consent.\n\nExclusion Criteria:\n\n* Neo-adjuvant chemotherapy or hormonotherapy\n* History of breast irradiation\n* Pregnant or breastfeeding woman\n* Patient under tutorship or curatorship\n* Patient who underwent a lumpectomy with a level-2 oncoplastic surgery (ex: breast reduction with an inverted-T remodeling)\n* Any other prior anti-tumor treatment\n* Other medical pathology which may interfere with the biologic evaluation, especially chronic auto-immune diseases.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}